June 14, 2012

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.

May 17, 2012

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

May 16, 2012

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

March 9, 2012

A regional retail pharmacy chain and a nearby school of pharmacy will collaborate on a study to evaluate the implementation of a pharmacogenetic program in a community pharmacy setting.

January 12, 2012

Prasco Labs will act as the distributor for an authorized generic version of a Shire anticonvulsant drug, the company said Thursday.

September 28, 2011

Chelsea Therapeutics International has applied for Food and Drug Administration approval of a drug for a disorder that affects patients with diseases like Parkinson's disease.

August 15, 2011

Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking standard therapies, according to results of a late-stage clinical trial.

July 26, 2011

The branded drugs division of Impax Labs has finished enrolling patients in a late-stage trial of a drug for Parkinson’s disease.

June 17, 2011

The Food and Drug Administration has approved a drug for arthritis made by Watson Pharmaceuticals, Watson said Friday.

June 6, 2011

The Food and Drug Administration has found manufacturing issues at a plant owned by generic drug maker Impax Labs, the drug maker said Monday.

April 20, 2011

Mylan has launched a generic drug for treating herpes, the company said Wednesday.

April 18, 2011

A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

April 1, 2011

An investigational drug for Parkinson’s disease was safe and effective, according to results of a late-stage clinical trial scheduled for presentation next week.

March 24, 2011

The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

March 24, 2011

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

March 22, 2011

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

August 10, 2010

The Food and Drug Administration is allowing kidney transplant patients to use a drug for...

July 13, 2010

The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the...

May 24, 2010

Teva Pharmaceuticals has introduced a generic version of a drug for genital herpes, shingles and...

May 2, 2010

Drug maker Abbott has sued a Watson Pharmaceuticals subsidiary over its attempt to market a...

March 30, 2010

Data from a long-term clinical trial may indicate a possible cancer risk in men taking...

March 29, 2010

The U.S. Patent and Trademark Office plans to uphold the patent protection of a blockbuster...

March 11, 2010

A popular drug for preventing blood clots may be less effective when taken by a...

February 8, 2010

The Food and Drug Administration has approved a generic hypertension drug made by India-based Lupin...